NOF Corporation
NOF Corporation (NOFCF) Financial Performance & Income Statement Overview
Explore the financials of NOF Corporation (NOFCF), including yearly and quarterly data on income, cash flow, and balance sheets.
NOF Corporation (NOFCF) Income Statement & Financial Overview
Review NOF Corporation NOFCF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $67.14B | $60.69B | $55.37B | $55.11B |
| Cost of Revenue | $46.68B | $38.51B | $35.74B | $32.23B |
| Gross Profit | $20.46B | $22.18B | $19.63B | $22.88B |
| Gross Profit Ratio | $0.30 | $0.37 | $0.35 | $0.42 |
| R&D Expenses | $0.00 | $1.89B | $1.82B | $1.92B |
| SG&A Expenses | $10.91B | $7.86B | $8.02B | $7.43B |
| Operating Expenses | $10.91B | $9.74B | $9.84B | $9.35B |
| Total Costs & Expenses | $57.59B | $48.25B | $45.58B | $41.58B |
| Interest Income | $163.00M | $118.00M | $0.00 | $94.00M |
| Interest Expense | $42.00M | $30.00M | $0.00 | $28.00M |
| Depreciation & Amortization | $2.76B | $1.78B | $1.71B | $1.68B |
| EBITDA | $14.17B | $14.15B | $11.52B | $17.61B |
| EBITDA Ratio | $0.21 | $0.23 | $0.21 | $0.32 |
| Operating Income | $9.55B | $12.44B | $9.79B | $13.53B |
| Operating Income Ratio | $0.14 | $0.20 | $0.18 | $0.25 |
| Other Income/Expenses (Net) | $1.79B | $2.65B | -$1.33B | $2.36B |
| Income Before Tax | $11.34B | $15.08B | $8.46B | $15.89B |
| Income Before Tax Ratio | $0.17 | $0.25 | $0.15 | $0.29 |
| Income Tax Expense | $2.42B | $4.45B | $2.47B | $4.84B |
| Net Income | $8.87B | $10.61B | $5.97B | $11.05B |
| Net Income Ratio | $0.13 | $0.17 | $0.11 | $0.20 |
| EPS | $37.73 | $44.78 | $25.07 | $46.30 |
| Diluted EPS | $37.73 | $44.78 | $25.07 | $46.30 |
| Weighted Avg Shares Outstanding | $235.07M | $236.98M | $238.07M | $238.60M |
| Weighted Avg Shares Outstanding (Diluted) | $235.07M | $236.98M | $238.07M | $238.60M |
Over the past four quarters, NOF Corporation demonstrated steady revenue growth, increasing from $55.11B in Q1 2024 to $67.14B in Q4 2024. Operating income reached $9.55B in Q4 2024, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $14.17B, reflecting operational efficiency. Net income dropped to $8.87B, with EPS at $37.73. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan